Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)?
Open Access
- 23 July 2013
- journal article
- Published by Wiley in BJU International
- Vol. 112 (4), 421-422
- https://doi.org/10.1111/bju.12177
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)BJU International, 2013
- Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP‐1/CCL2 and VCAM‐1, in vitroBJU International, 2012
- The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia TreatmentKorean Journal of Urology, 2010
- The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE TrialEuropean Urology, 2007
- Benign prostatic hyperplasia: age-related tissue-remodelingExperimental Gerontology, 2005
- BPH and Inflammation: Pharmacological Effects of Permixon on Histological and Molecular Inflammatory Markers. Results of a Double Blind Pilot Clinical AssayEuropean Urology, 2003